Filtered By:
Source: Redox Biology
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 62 results found since Jan 2013.
Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness
Publication date: 2014 Source:Redox Biology, Volume 3 Author(s): Christopher B. Forsyth , Robin M. Voigt , Ali. Keshavarzian Chronic alcohol use can result in many pathological effects including alcoholic liver disease (ALD). While alcohol is necessary for the development of ALD, only 20–30% of alcoholics develop alcoholic steatohepatitis (ASH) with progressive liver disease leading to cirrhosis and liver failure (ALD). This suggests that while chronic alcohol consumption is necessary it is not sufficient to induce clinically relevant liver damage in the absence of a secondary risk factor. Studies in rodent models and ...
Source: Redox Biology - December 14, 2014 Category: Biology Source Type: research
Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation
Publication date: 2014 Source:Redox Biology, Volume 2 Author(s): Keisuke Sato , Kaori Yama , Yu Murao , Ryosuke Tatsunami , Yoshiko Tampo Epalrestat (EPS), approved in Japan, is the only aldose reductase inhibitor that is currently available for the treatment of diabetic neuropathy. Here we report that EPS at near-plasma concentration increases the intracellular levels of glutathione (GSH), which is important for protection against oxidative injury, through transcription regulation. Treatment of Schwann cells with EPS caused a dramatic increase in intracellular GSH levels. EPS increased the mRNA levels of γ-glutamylcyst...
Source: Redox Biology - October 12, 2014 Category: Biology Source Type: research
